PURPOSE: Widespread consensus exists about the importance of addressing patient safety issues in oncology, yet our understanding of the frequency, spectrum, and preventability of adverse events (AEs) across cancer care is limited. METHODS: We developed a screening tool to detect AEs across cancer care settings through medical record review. Members of the study team reviewed the scientific literature and obtained structured input from an external multidisciplinary panel of clinicians by using a modified Delphi process. RESULTS: The screening tool comprises 76 triggers-readily identifiable findings to screen for possible AEs that occur during cancer care. Categories of triggers are general care, vital signs, medication related, laboratory tests, other orders, and consultations. CONCLUSION: Although additional testing is required to assess its performance characteristics, this tool may offer an efficient mechanism for identifying possibly preventable AEs in oncology and serve as an instrument for quality improvement.
PURPOSE: Widespread consensus exists about the importance of addressing patient safety issues in oncology, yet our understanding of the frequency, spectrum, and preventability of adverse events (AEs) across cancer care is limited. METHODS: We developed a screening tool to detect AEs across cancer care settings through medical record review. Members of the study team reviewed the scientific literature and obtained structured input from an external multidisciplinary panel of clinicians by using a modified Delphi process. RESULTS: The screening tool comprises 76 triggers-readily identifiable findings to screen for possible AEs that occur during cancer care. Categories of triggers are general care, vital signs, medication related, laboratory tests, other orders, and consultations. CONCLUSION: Although additional testing is required to assess its performance characteristics, this tool may offer an efficient mechanism for identifying possibly preventable AEs in oncology and serve as an instrument for quality improvement.
Authors: Tien Hoang; Suzanne E Dahlberg; Joan H Schiller; Minesh P Mehta; Thomas J Fitzgerald; Steven A Belinsky; David H Johnson Journal: J Clin Oncol Date: 2012-01-23 Impact factor: 44.544
Authors: Matthew J Schuchert; Brian L Pettiford; Arjun Pennathur; Ghulam Abbas; Omar Awais; John Close; Arman Kilic; Robert Jack; James R Landreneau; Joshua P Landreneau; David O Wilson; James D Luketich; Rodney J Landreneau Journal: J Thorac Cardiovasc Surg Date: 2009-12 Impact factor: 5.209
Authors: Tracy E Spinks; Ronald Walters; Thomas W Feeley; Heidi Wied Albright; Victoria S Jordan; John Bingham; Thomas W Burke Journal: Health Aff (Millwood) Date: 2011-04 Impact factor: 6.301
Authors: Christopher P Landrigan; Gareth J Parry; Catherine B Bones; Andrew D Hackbarth; Donald A Goldmann; Paul J Sharek Journal: N Engl J Med Date: 2010-11-25 Impact factor: 91.245
Authors: Thea Otto Mattsson; Janne Lehmann Knudsen; Jens Lauritsen; Kim Brixen; Jørn Herrstedt Journal: BMJ Qual Saf Date: 2013-02-27 Impact factor: 7.035
Authors: William Runciman; Peter Hibbert; Richard Thomson; Tjerk Van Der Schaaf; Heather Sherman; Pierre Lewalle Journal: Int J Qual Health Care Date: 2009-02 Impact factor: 2.038
Authors: Allison Lipitz-Snyderman; David Classen; David Pfister; Aileen Killen; Coral L Atoria; Elizabeth Fortier; Andrew S Epstein; Christopher Anderson; Saul N Weingart Journal: J Oncol Pract Date: 2017-01-17 Impact factor: 3.840
Authors: Allison Lipitz-Snyderman; David Pfister; David Classen; Coral L Atoria; Aileen Killen; Andrew S Epstein; Christopher Anderson; Elizabeth Fortier; Saul N Weingart Journal: Cancer Date: 2017-08-17 Impact factor: 6.860
Authors: Lipika Samal; Srijesa Khasnabish; Cathy Foskett; Katherine Zigmont; Arild Faxvaag; Frank Chang; Marsha Clements; Sarah Collins Rossetti; Anuj K Dalal; Kathleen Leone; Stuart Lipsitz; Anthony Massaro; Ronen Rozenblum; Kumiko O Schnock; Catherine Yoon; David W Bates; Patricia C Dykes Journal: J Patient Saf Date: 2022-07-21 Impact factor: 2.243
Authors: Saul N Weingart; Coral L Atoria; David Pfister; David Classen; Aileen Killen; Elizabeth Fortier; Andrew S Epstein; Christopher Anderson; Allison Lipitz-Snyderman Journal: J Patient Saf Date: 2021-12-01 Impact factor: 2.844
Authors: Saul N Weingart; Jason Nelson; Benjamin Koethe; Omar Yaghi; Stephan Dunning; Albert Feldman; David Kent; Allison Lipitz-Snyderman Journal: Cancer Med Date: 2020-04-13 Impact factor: 4.452
Authors: Saul N Weingart; Jason Nelson; Benjamin Koethe; Omar Yaghi; Stephan Dunning; Albert Feldman; David M Kent; Allison Lipitz-Snyderman Journal: Cancer Med Date: 2020-01-03 Impact factor: 4.452